Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement

Reuters

06-05

Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement

New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2541020470"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541020470\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2541020470?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 20:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541020470","market":"us","top_or_hot":-1,"title":"Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-05 20:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRM","symbol_name":"MEDIROM Healthcare Technologies, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLbpfsFm:1","article_id":"2541020470","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541020470","pubTimestamp":1749126057,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. , a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRM":"MEDIROM Healthcare Technologies, Inc.","BK4192":"特殊消费者服务"},"translate_title":"Medirom Healthcare Technologies Inc.在满足最低投标价格要求后重新获得纳斯达克合规性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRM":0.9},"content_text":"Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n    \n\n        New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}